Our results suggest that CysLT1 antagonists may have protective effects on the hypoxic heart, and improve the oxygen supply to areas of myocardial ischemia, for instance during episodes of sleep apnea. The gene discussed is CYSLTR1; the disease is sleep apnea syndrome.